etoposide 20mg/ml concentrate for solution for infusion
actavis group ptc ehf - etoposide - concentrate for solution for infusion - 20 milligram(s)/millilitre - podophyllotoxin derivatives; etoposide
etoposide 20 mg/ml concentrate for solution for infusion
fresenius kabi oncology plc - etoposide - concentrate for solution for infusion - 20 milligram(s)/millilitre - podophyllotoxin derivatives; etoposide
etoposide-teva 20 mg/ml concentrate for solution for infusion
teva pharma b.v. - etoposide - concentrate for solution for infusion - 20 milligram(s)/millilitre - podophyllotoxin derivatives; etoposide
vepesid 100 mg capsule, soft
bristol-myers squibb pharmaceuticals uc - etoposide - capsule, soft - 100 milligram(s) - podophyllotoxin derivatives; etoposide
vepesid 50 mg capsule, soft
bristol-myers squibb pharmaceuticals uc - etoposide - capsule - 50 mg milligram(s) - podophyllotoxin derivatives; etoposide
etoposide 20mg/ml concentrate for solution for infusion
accord healthcare ireland ltd. - etoposide - concentrate for solution for infusion - 20 milligram(s)/millilitre - podophyllotoxin derivatives; etoposide
etoposide 20 mg/ml concentrate for solution for infusion
fresenius kabi deutschland gmbh - etoposide - concentrate for solution for infusion - 20 milligram(s)/millilitre - podophyllotoxin derivatives; etoposide
vepesid 100 mg capsule, soft
cheplapharm arzneimittel gmbh - etoposide - capsule, soft - 100 milligram(s) - podophyllotoxin derivatives; etoposide
vepesid 50 mg capsule, soft
cheplapharm arzneimittel gmbh - etoposide - capsule, soft - 50 milligram(s) - podophyllotoxin derivatives; etoposide
etoposide teva
abic marketing ltd, israel - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - etoposide - etoposide - hodgkin's disease. malignant (non-hodgkin's) lymphomas, especially of the histiocytic variety.acute non-lymphocytic leukemia. management of refractory testicular tumors and of small cell lung cancer.